Company / R&D per Share
Organogenesis Holdings Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.35
FY2025
5-year range
$0.12 / $0.35
FY2021-FY2025
Trend
+16.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has increased for 7 consecutive years, from $0.09 in FY2018 to $0.35 in FY2025.
Based on SEC 10-K filings.
0.35 in FY2025 with a 5-year CAGR of +28.1%.
Improved from $0.23 to $0.35 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +31.3%
- 5-Year CAGR
- +28.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Organogenesis Holdings Inc.'s r&d per share has grown for 7 consecutive years.
- In FY2025, r&d per share increased 16.6% year-over-year.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.35 | +16.6% |
| FY2024 | $0.30 | +28.9% |
| FY2023 | $0.23 | +50.4% |
| FY2022 | $0.16 | +34.7% |
| FY2021 | $0.12 | +13.1% |
| FY2020 | $0.10 | +3.1% |
| FY2019 | $0.10 | +6.0% |
| FY2018 | $0.09 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026